| Pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated |
ЕU/1/09/590/001 |
Prevenar 13, Suspension for injection, 0.5, ml, Pack: 1 pre-fylled syringe |
Wyeth Lederle Vaccine S.A., Белгия |
Wyeth Pharmaceuticals UK |
94.53 |
18.91 |
113.44 |
4% |
3.78 |
98.31 |
19.66 |
117.97 |
16% |
15.12 |
113.43 |
22.69 |
136.12 |
|
КЦ-1969/26.01.2011 |
09.02.2011 |
09.02.2011 |
Неактивен |
2862 |
| Pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated |
ЕU/1/09/590/003 |
Prevenar 13, Suspension for injection, 0.5, ml, Pack: 10 |
Pfizer Europe MA EEIG, Белгия |
Wyeth Pharmaceuticals UK; Pfizer Manufacturing Belgium N.V. Rijksweg 12, B-2870 Puurs, Белгия |
829.86 |
165.97 |
995.83 |
4% |
10 |
839.86 |
167.97 |
1007.83 |
16% |
25 |
864.86 |
172.97 |
1037.83 |
Промяна на обстоятелства НСР-17472/13.12.2018; НСР-17914/07.02.2019 |
КЦРР-2217/06.02.2013; НСР-13157/17.07.2017 |
01.08.2017 |
02.03.2019 |
Активен |
1653 |
| Pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated |
ЕU/1/09/590/003 |
Prevenar 13, Suspension for injection, 0.5, ml, Pack: 10 |
Pfizer Europe MA EEIG, Белгия |
Wyeth Pharmaceuticals UK |
829.86 |
165.97 |
995.83 |
4% |
10 |
839.86 |
167.97 |
1007.83 |
16% |
25 |
864.86 |
172.97 |
1037.83 |
Промяна на обстоятелства НСР-17472/13.12.2018 |
КЦРР-2217/06.02.2013; НСР-13157/17.07.2017 |
01.08.2017 |
02.01.2019 |
Неактивен |
1653 |
| Pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated |
ЕU/1/09/590/003 |
Prevenar 13, Suspension for injection, 0.5, ml, Pack: 10 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals UK |
829.86 |
165.97 |
995.83 |
4% |
10 |
839.86 |
167.97 |
1007.83 |
16% |
25 |
864.86 |
172.97 |
1037.83 |
|
КЦРР-2217/06.02.2013; НСР-13157/17.07.2017 |
01.08.2017 |
02.09.2017 |
Неактивен |
1653 |
| Pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated |
ЕU/1/09/590/003 |
Prevenar 13, Suspension for injection, 0.5, ml, Pack: 10 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals UK |
838.09 |
167.62 |
1005.71 |
4% |
10 |
848.09 |
169.62 |
1017.71 |
16% |
25 |
873.09 |
174.62 |
1047.71 |
|
КЦРР-2217/06.02.2013 |
03.03.2013 |
03.03.2013 |
Неактивен |
1653 |
| Pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated |
ЕU/1/09/590/003 |
Prevenar 13, Suspension for injection, 0.5, ml, Pack: 10 |
Pfizer Limited, Обединено Кралство |
Wyeth Pharmaceuticals UK |
945.12 |
189.02 |
1134.14 |
4% |
10 |
955.12 |
191.02 |
1146.14 |
16% |
25 |
980.12 |
196.02 |
1176.14 |
КЦPP-1462/02.10.2012 ; КЦPP-1914/15.12.2012 г промяна на обстоятелства |
КЦ-1894/02.11.2010 |
16.11.2010 |
16.11.2010 |
Неактивен |
1653 |
| Finasteride |
II-2654/30.07.2008 |
Prezepa, Film coated tablet, 5, mg, Pack: 30 |
Тева Фармасютикълс България ЕООД, България |
Teva UK Ltd., UK; Pharmachemie B.V., The Netherlands; TEVA Pharmaceutical Works Private Limited company, Hungary; Teva Sante, France |
10.84 |
2.17 |
13.01 |
6% |
0.65 |
11.49 |
2.3 |
13.79 |
18% |
1.95 |
13.44 |
2.69 |
16.13 |
цената е заличена с решение НСР-1188/13.09.2013 |
КЦРР-741/07.06.2012 |
31.07.2012 |
31.07.2012 |
Заличен |
1243 |
| Finasteride |
II-2654/30.07.2008 |
Prezepa, Film coated tablet, 5, mg, Pack: 30 |
Тева Фармасютикълс България ЕООД, България |
Teva UK Ltd., UK; Pharmachemie B.V., The Netherlands; TEVA Pharmaceutical Works Private Limited company, Hungary; Teva Sante, France |
29.55 |
5.91 |
35.46 |
8% |
2.36 |
31.91 |
6.38 |
38.29 |
20% |
5.91 |
37.82 |
7.56 |
45.38 |
|
КЦ-700/09.03.2009 |
24.03.2009 |
24.03.2009 |
Неактивен |
1243 |
| Darunavir |
EU/1/06/380/001 |
Prezista, Film coated tablet, 300, mg, Pack: 120 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA, Italy |
1254.27 |
250.85 |
1505.12 |
6% |
15 |
1269.27 |
253.85 |
1523.12 |
18% |
30 |
1299.27 |
259.85 |
1559.12 |
цената се заличава КЦРР-931/04.07.2012 |
КЦ-380/07.01.2009 |
27.07.2012 |
27.07.2012 |
Заличен |
407 |
| Darunavir |
EU/1/06/380/002 |
PREZISTA, Film coated tablet, 600, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen –Cilag SpA, Италия |
997.55 |
199.51 |
1197.06 |
4% |
10 |
1007.55 |
201.51 |
1209.06 |
16% |
25 |
1032.55 |
206.51 |
1239.06 |
|
НСР-4998/05.11.2014; НСР-9721/07.07.2016; НСР-13171/17.07.2017; НСР-16865/28.09.2018 |
13.10.2018 |
02.11.2018 |
Активен |
3333 |
| Darunavir |
EU/1/06/380/002 |
PREZISTA, Film coated tablet, 600, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen –Cilag SpA, Италия |
1016.99 |
203.4 |
1220.39 |
4% |
10 |
1026.99 |
205.4 |
1232.39 |
16% |
25 |
1051.99 |
210.4 |
1262.39 |
|
НСР-4998/05.11.2014; НСР-9721/07.07.2016; НСР-13171/17.07.2017 |
01.08.2017 |
02.09.2017 |
Неактивен |
3333 |
| Darunavir |
EU/1/06/380/002 |
PREZISTA, Film coated tablet, 600, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen –Cilag SpA, Италия |
1023.62 |
204.72 |
1228.34 |
4% |
10 |
1033.62 |
206.72 |
1240.34 |
16% |
25 |
1058.62 |
211.72 |
1270.34 |
|
НСР-4998/05.11.2014; НСР-9721/07.07.2016 |
02.08.2016 |
02.08.2016 |
Неактивен |
3333 |
| Darunavir |
EU/1/06/380/003 |
PREZISTA, Film coated tablet, 400, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA, Italy |
685.54 |
137.11 |
822.65 |
4% |
10 |
695.54 |
139.11 |
834.65 |
16% |
25 |
720.54 |
144.11 |
864.65 |
|
НСР-5751/26.02.2015.; НСР-10080/18.08.2016 |
12.03.2015 |
02.10.2016 |
Заличен |
3628 |
| Darunavir |
EU/1/06/380/003 |
PREZISTA, Film coated tablet, 400, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA, Italy |
685.54 |
137.11 |
822.65 |
4% |
10 |
695.54 |
139.11 |
834.65 |
16% |
25 |
720.54 |
144.11 |
864.65 |
|
НСР-5751/26.02.2015. |
12.03.2015 |
12.03.2015 |
Неактивен |
3628 |
| Darunavir |
EU/1/06/380/002 |
PREZISTA, Film coated tablet, 600, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen –Cilag SpA, Италия |
1025.11 |
205.02 |
1230.13 |
4% |
10 |
1035.11 |
207.02 |
1242.13 |
16% |
25 |
1060.11 |
212.02 |
1272.13 |
|
НСР-4998/05.11.2014 |
19.11.2014 |
19.11.2014 |
Неактивен |
3333 |
| Darunavir |
EU/1/06/380/003 |
PREZISTA, Film coated tablet, 400, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA, Italy |
702.36 |
140.47 |
842.83 |
4% |
10 |
712.36 |
142.47 |
854.83 |
16% |
25 |
737.36 |
147.47 |
884.83 |
|
НСР-3989/30.06.2014 |
15.07.2014 |
15.07.2014 |
Неактивен |
3628 |
| Darunavir |
EU/1/06/380/002 |
PREZISTA, Film coated tablet, 600, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen –Cilag SpA, Италия |
1052.35 |
210.47 |
1262.82 |
4% |
10 |
1062.35 |
212.47 |
1274.82 |
16% |
25 |
1087.35 |
217.47 |
1304.82 |
|
НСР-1731/21.11.2013 |
20.03.2014 |
20.03.2014 |
Неактивен |
3333 |
| Darunavir |
EU/1/06/380/003 |
PREZISTA, Film coated tablet, 400, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA, Italy |
722.09 |
144.42 |
866.51 |
4% |
10 |
732.09 |
146.42 |
878.51 |
16% |
25 |
757.09 |
151.42 |
908.51 |
|
НСР-1618/01.11.2013 |
25.11.2013 |
25.11.2013 |
Неактивен |
3628 |
| Darunavir |
EU/1/06/380/002 |
PREZISTA, Film coated tablet, 600, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen –Cilag SpA, Италия |
1113.79 |
222.76 |
1336.55 |
4% |
10 |
1123.79 |
224.76 |
1348.55 |
16% |
25 |
1148.79 |
229.76 |
1378.55 |
|
КЦРР-1165/08.08.2012 |
25.09.2012 |
25.09.2012 |
Неактивен |
3333 |
| Darunavir |
EU/1/06/380/002 |
PREZISTA, Film coated tablet, 600, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen –Cilag SpA, Италия |
1254.27 |
250.85 |
1505.12 |
4% |
10 |
1264.27 |
252.85 |
1517.12 |
16% |
25 |
1289.27 |
257.85 |
1547.12 |
|
КЦ-1364/12.02.2010 |
03.03.2010 |
03.03.2010 |
Неактивен |
3333 |
| Darunavir |
EU/1/06/380/003 |
PREZISTA, Film coated tablet, 400, mg, Pack: 60 |
Janssen-Cilag International N.V., Белгия |
Janssen-Cilag SpA, Italy |
835.53 |
167.11 |
1002.64 |
4% |
10 |
845.53 |
169.11 |
1014.64 |
16% |
25 |
870.53 |
174.11 |
1044.64 |
корек КЦ-1356/04.02.2010 |
КЦ-1288/19.01.2010 |
03.02.2010 |
03.02.2010 |
Неактивен |
3628 |
| Darunavir |
EU/1/06/380/007 |
PREZISTA, Film coated tablet, 800, mg, Pack: 30 |
Janssen-Cilag International N.V., Белгия |
Janssen – Cilag SpA, Италия |
666.47 |
133.29 |
799.76 |
4% |
10 |
676.47 |
135.29 |
811.76 |
16% |
25 |
701.47 |
140.29 |
841.76 |
|
НСР-8441/07.03.2016; НСР-10929/17.11.2016; НСР-13855/14.09.2017; НСР-17052/26.10.2018 |
10.11.2018 |
02.12.2018 |
Активен |
4025 |
| Darunavir |
EU/1/06/380/007 |
PREZISTA, Film coated tablet, 800, mg, Pack: 30 |
Janssen-Cilag International N.V., Белгия |
Janssen – Cilag SpA, Италия |
677.95 |
135.59 |
813.54 |
4% |
10 |
687.95 |
137.59 |
825.54 |
16% |
25 |
712.95 |
142.59 |
855.54 |
|
НСР-8441/07.03.2016; НСР-10929/17.11.2016; НСР-13855/14.09.2017 |
29.09.2017 |
02.10.2017 |
Неактивен |
4025 |
| Darunavir |
EU/1/06/380/007 |
PREZISTA, Film coated tablet, 800, mg, Pack: 30 |
Janssen-Cilag International N.V., Белгия |
Janssen – Cilag SpA, Италия |
682.13 |
136.43 |
818.56 |
4% |
10 |
692.13 |
138.43 |
830.56 |
16% |
25 |
717.13 |
143.43 |
860.56 |
|
НСР-8441/07.03.2016; НСР-10929/17.11.2016 |
02.01.2017 |
02.01.2017 |
Неактивен |
4025 |
| Darunavir |
EU/1/06/380/007 |
PREZISTA, Film coated tablet, 800, mg, Pack: 30 |
Janssen-Cilag International N.V., Белгия |
Janssen – Cilag SpA, Италия |
685.79 |
137.16 |
822.95 |
4% |
10 |
695.79 |
139.16 |
834.95 |
16% |
25 |
720.79 |
144.16 |
864.95 |
|
НСР-8441/07.03.2016 |
22.03.2016 |
22.03.2016 |
Неактивен |
4025 |